Zobrazeno 1 - 10
of 35
pro vyhledávání: '"J J Laskin"'
Autor:
T. Aranyavalai, C. Jalayondeja, W. Jalayondeja, S. Pichaiyongwongdee, J. Kaewkungwal, J. J. Laskin
Publikováno v:
BMC Geriatrics, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Walking is the most common population-wide campaign for health promotion in older people. However, the cutoff threshold for walking steps/day to identify the older people who are at risk of falling is not recommended. Therefore, t
Externí odkaz:
https://doaj.org/article/4f73221298cb4e56853fe7e668325b10
Autor:
J. J. Laskin, T. Aranyavalai, Sopa Pichaiyongwongdee, Wattana Jalayondeja, Jaranit Kaewkungwal, Chutima Jalayondeja
Publikováno v:
BMC Geriatrics, Vol 20, Iss 1, Pp 1-11 (2020)
BMC Geriatrics
BMC Geriatrics
Background Walking is the most common population-wide campaign for health promotion in older people. However, the cutoff threshold for walking steps/day to identify the older people who are at risk of falling is not recommended. Therefore, the object
Autor:
Euan A. Ashley, Robert S. Burnham, Garry D. Wheeler, D C Cumming, L M Olenik, J J Laskin, Robert D. Steadward
Publikováno v:
Spinal Cord. 31:593-605
The purpose of the investigation was to examine the safety and efficacy of functional electrical stimulation (FES)-assisted hydraulic resistance training in improving cardiovascular fitness in persons with spinal cord injuries. The cardiopulmonary re
Autor:
J J Laskin, Vicki J. Harber, Euan A. Ashley, Garry D. Wheeler, RD Steadward, L M Olenik, D Sloley, Robert S. Burnham, David C. Cumming
Publikováno v:
Spinal cord. 34(5)
Functional electrical stimulation (FES) assisted resistance training has been effective in increasing muscular strength and endurance in spinal cord injured men and women in preparation for FES-assisted cycle programs and for FES-assisted standing an
Publikováno v:
Paraplegia. 33(3)
Shoulder dysfunction due to regular wheelchair use is a common problem among people with spinal cord injuries. As a remedial measure, strengthening of the scapular retractor muscles has been suggested. Electromyographical analysis was utilized to exa
Publikováno v:
Paraplegia. 31(8)
Recently a FES (functional electrical stimulation)-assisted rowing machine was developed to enhance cardiovascular training in people with spinal cord injuries. The machine was assessed in terms of its efficacy as a training tool. Six patients who we
Autor:
Titmuss E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Milne K; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Jones MR; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Ng T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada., Topham JT; Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada., Brown SD; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Schaeffer DF; Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada., Kalloger S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada., Wilson D; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Corbett RD; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Williamson LM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Mungall K; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Holt RA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada., Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Laskin J; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Lim HJ; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Nov 14; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 14.
Autor:
Titmuss E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Milne K; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada., Jones MR; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Ng T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada., Topham JT; Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada., Brown SD; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Schaeffer DF; Pancreas Centre BC, Vancouver, BC V5Z 1G1, Canada., Kalloger S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada., Wilson D; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Corbett RD; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Williamson LM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Mungall K; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Holt RA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada., Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada., Laskin J; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Lim HJ; Department of Medical Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 20; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 20.
Autor:
Pleasance E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Bohm A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver; Department of Medicine, University of British Columbia, Vancouver., Williamson LM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Nelson JMT; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Shen Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Bonakdar M; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Titmuss E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Csizmok V; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Wee K; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Hosseinzadeh S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver; Department of Medicine, University of British Columbia, Vancouver., Grisdale CJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Reisle C; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Taylor GA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Lewis E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Jones MR; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Bleile D; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Sadeghi S; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Zhang W; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Davies A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Pellegrini B; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Wong T; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Chan SK; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Mungall KL; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Chuah E; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Moore RA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Zhao Y; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Deol B; Department of Medical Oncology, BC Cancer, Vancouver., Fisic A; Department of Medical Oncology, BC Cancer, Vancouver., Fok A; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver., Regier DA; Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer, Vancouver., Weymann D; Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer, Vancouver., Schaeffer DF; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver; Pancreas Centre BC, Vancouver., Young S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver., Yip S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver., Schrader K; Hereditary Cancer Program, BC Cancer, Vancouver; Department of Medical Genetics, University of British Columbia, Vancouver., Levasseur N; Department of Medical Oncology, BC Cancer, Vancouver., Taylor SK; Department of Medical Oncology, BC Cancer, Kelowna., Feng X; Department of Medical Oncology, BC Cancer, Victoria., Tinker A; Department of Medical Oncology, BC Cancer, Vancouver., Savage KJ; Department of Medical Oncology, BC Cancer, Vancouver., Chia S; Department of Medical Oncology, BC Cancer, Vancouver., Gelmon K; Department of Medical Oncology, BC Cancer, Vancouver., Sun S; Department of Medical Oncology, BC Cancer, Vancouver., Lim H; Department of Medical Oncology, BC Cancer, Vancouver., Renouf DJ; Department of Medical Oncology, BC Cancer, Vancouver; Pancreas Centre BC, Vancouver., Jones SJM; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver; Department of Medical Genetics, University of British Columbia, Vancouver; Department of Molecular Biology and Biochemistry, Simon Fraser University, Vancouver, Canada., Marra MA; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver; Department of Medical Genetics, University of British Columbia, Vancouver., Laskin J; Department of Medical Oncology, BC Cancer, Vancouver. Electronic address: jlaskin@bccancer.bc.ca.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Sep; Vol. 33 (9), pp. 939-949. Date of Electronic Publication: 2022 Jun 09.
Autor:
Laskin J; Division of Medical Oncology, Department of Medicine, University of British Columbia, BC Cancer, Vancouver, BC, Canada. Electronic address: jlaskin@bccancer.bc.ca., Liu SV; Georgetown University Medical Center, Washington, USA., Tolba K; Oregon Health and Science University, Portland, OR, USA., Heining C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden and German Cancer Research Center (DKFZ), Dresden, Germany; Center for Personalized Oncology, NCT Dresden and University Hospital Carl Gustav Carus Dresden at Technical University Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany., Schlenk RF; National Center of Tumor Diseases Heidelberg, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany., Cheema P; William Osler Health System, University of Toronto, Toronto, ON, Canada., Cadranel J; Assistance Publique Hôpitaux de Paris, Hôpital Tenon and Sorbonne Université, Paris, France., Jones MR; QIAGEN Digital Insights, QIAGEN Inc., Redwood City, CA, USA., Drilon A; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cseh A; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Gyorffy S; AstraZeneca Canada Ltd, Mississauga, ON, Canada., Solca F; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Duruisseaux M; Hospices Civils de Lyon Cancer Institute, Anticancer Antibodies Lab Cancer Research Center of Lyon INSERM 1052 CNRS 528, Université Claude Bernard Lyon 1, Lyon, France.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Dec; Vol. 31 (12), pp. 1693-1703. Date of Electronic Publication: 2020 Sep 09.